Thyrocare Technologies to consider report of valuation of wholly owned subsidiary

20 Sep 2019 Evaluate

Thyrocare Technologies is going to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the company's shareholding in NHL or dispose it. The meeting of the Board of Directors of the company will be held on September 21, 2019, to consider the same. 

Thyrocare Technologies provides hospital services and are the industry leader, trend setter and innovators in Indian Diagnostic industry.

Thyrocare Tech. Share Price

922.20 -26.85 (-2.83%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7000.00
Max Healthcare Inst 1008.35
Narayana Hrudayalay 1265.30
Aster DM Healthcare 442.70
Global Health 1105.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.